Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
New York Provides Data-Backed Proof That Stronger Utilization Review is a Cost-Control Strategy
With severity and medical costs rising in many states, leaders are looking hard at what actually controls paid medical.
Workers' Comp
Article
Settling Future Medical? Don’t Let Medicare Turn It Into a Reopen
You are trying to close a file. Then Medicare shows up late and turns a clean settlement into a messy one.
Business Insurance
In the News
What a rise in older workers means for comp
Workers' Comp
Article
Ask The Pharmacist: The Hidden Risks of Gabapentin in Workers’ Compensation
What is gabapentin and why is it so commonly prescribed?Gabapentin was approved by the
Mitchell
Article
Plugged-In: EV Collision Insights 2025 Year in Review
Do
Mitchell
News Release
Electric Vehicle Collision Claims Rise 14% in the U.S. and 24% in Canada Even as Sales of New Models Slow
SAN DIEGO, Calif.—Mitchell, a leader in the development of innovative auto physical damage